Aarti Drugs Limited (BSE: 524348)
Health Care · Pharmaceuticals · IN
Rs413.10
-2.12% today · -20.2% 1Y
Aarti Drugs Limited (BSE: 524348) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $389.58M.
Over the last twelve months the share price has lost 20.2%, trading between 318.60 and 533.60.
Tweenvest scores Aarti Drugs Limited across four factors: quality 67/100, value 70/100, growth 28/100, dividend 67/100. Its strongest factor is value.
524348 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $389.58M
- Revenue (TTM)
- $283.19M
- P/E
- 19.72
- EPS
- 20.95
- Dividend yield
- 0.48%
- Beta (5Y)
- 0.31
- 52-week high
- Rs533.60
- 52-week low
- Rs318.60
- Avg volume (3M)
- —
- Shares outstanding
- 91.27M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Atea Pharmaceuticals, Inc.NasdaqGS: AVIR | $413.05M | $5.15 | -0.10% |
| JCR Pharmaceuticals Co., Ltd.TSE: 4552 | $407.69M | ¥529.00 | +9.52% |
| Allergy Therapeutics plcAIM: AGY | $398.04M | £0.05 | 0.00% |
| Shandong Sito Bio-technology Co., Ltd.SZSE: 300583 | $394.52M | CN¥13.93 | +1.68% |
| Foresee Pharmaceuticals Co., Ltd.TPEX: 6576 | $385.29M | NT$78.20 | -1.01% |
| Unichem Laboratories LimitedBSE: 506690 | $385.27M | Rs529.60 | -1.10% |
| KYORIN Pharmaceutical Co., Ltd.TSE: 4569 | $382.76M | ¥1,055.00 | -0.94% |
| Kwality Pharmaceuticals LimitedBSE: 539997 | $381.97M | Rs3,562.70 | -0.27% |
Figures last refreshed Oct 11, 2026.